|
KIAA0753 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63147273468667E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88271620515934E-12 |
| Normal-vs-Stage2 |
4.977800E-03 |
| Normal-vs-Stage3 |
8.559700E-03 |
| Normal-vs-Stage4 |
1.029240E-01 |
| Stage1-vs-Stage2 |
8.023200E-01 |
| Stage1-vs-Stage3 |
6.675900E-02 |
| Stage1-vs-Stage4 |
4.003400E-03 |
| Stage2-vs-Stage3 |
1.901210E-01 |
| Stage2-vs-Stage4 |
5.051900E-02 |
| Stage3-vs-Stage4 |
4.108000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19824158875781E-14 |
| Normal-vs-AfricanAmerican |
2.78160000033445E-07 |
| Normal-vs-Asian |
1.395850E-02 |
| Caucasian-vs-AfricanAmerican |
6.303800E-01 |
| Caucasian-vs-Asian |
3.952800E-01 |
| AfricanAmerican-vs-Asian |
4.841600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99840144432528E-14 |
| Normal-vs-Female |
9.04119999978192E-08 |
| Male-vs-Female |
9.553400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.032400E-04 |
| Normal-vs-Extreme_Weight |
2.20600000488957E-08 |
| Normal-vs-Obese |
1.39419999989343E-08 |
| Normal-vs-Extreme_Obese |
3.031700E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.781600E-01 |
| Normal_Weight-vs-Obese |
2.191600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.498400E-01 |
| Extreme_Weight-vs-Obese |
3.939400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.851600E-01 |
| Obese-vs-Extreme_Obese |
6.857400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.607300E-04 |
| Normal-vs-Age(41-60Yrs) |
6.10622663543836E-15 |
| Normal-vs-Age(61-80Yrs) |
2.77220024713642E-10 |
| Normal-vs-Age(81-100Yrs) |
5.815200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.742200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.946980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.756400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.554500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.078900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.985800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.733800E-01 |
| Normal-VS-KIRP CIMP |
1.098210E-01 |
| Normal-VS-Unclassified PRCC |
1.992290E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.148230E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.314160E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.008300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.774300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.539800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.361200E-04 |
| Normal-vs-N1 |
1.559030E-03 |
| Normal-vs-N2 |
6.500200E-01 |
| N0-vs-N1 |
6.838400E-01 |
| N0-vs-N2 |
1.810150E-01 |
| N1-vs-N2 |
9.858300E-02 |
|
|
